Miscellaneous
CME Available: https://auau.auanet.org/node/33881 At the conclusion of this course, participants will be able to: 1. Describe the various 3rd line therapies available to treat refractory OAB and will be able to discuss the pros and cons of each of the 3rd line therapies available to treat refractory OAB. 2. Explain with the current data regarding outcomes of PTNS, onabotulinumtoxinA, and sacral neuromodulation for treatment of refractory OAB. 3. Outline how to perform PTNS. Report how to perform onabotunlinumtoxinA injections in the office or outpatient setting. 5. Review techniques in optimal lead placement for sacral neuromodulation, programming and troubleshooting. ACKNOWLEDGEMENTS Independent educational grant support provided by: Astellas AbbVie Medtronic Urovant Sciences, Inc.